Navigation Links
Valopicitabine in Medical News

Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results

...V), respectively, and the amortization of the up-front fees received by Idenix in connection with Novartis' license of telbivudine, valtorcitabine and valopicitabine and product sales of Tyzeka/Sebivo. Idenix reported a net loss of $30.5 million, or a loss of $0.54 per basic and diluted share for the third quarter ...
Valopicitabine in Medical Technology

Idenix Reports Results from Two Phase IIb Studies of the Combination of Valopicitabine and Pegylated Interferon in Hepatitis C Genotype-1 Patients at the 42nd Annual Meeting of the European Association for the Study of the Liver

Additional Preclinical Data Presented on Valopicitabine Combined with an Investigational Protease Inhibitor BARCELONA, Spain, April 12, 2007 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. today announced results from two phase IIb studies of the novel combination of valopicitabine (NM283) ...

Idenix Announces Data Presentations at the 2007 Digestive Disease Week Meeting

...ster session beginning on Monday, May 21, 2007 at 8:00 a.m. EDT. About valopicitabine (NM283) valopicitabine is an investigational HCV RNA polymerase inhibitor being evaluated in ongoi...

Valopicitabine Combined with Standard of Care Cleared Hepatitis C Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a Phase II Trial

... ~ valopicitabine achieved both primary and secondary endpoints of s...s. Patients in arm A (n=39) received 200 mg/day of valopicitabine and pegylated interferon alpha 2a; patients in arm...day lead-in period, where patients received either valopicitabine or placebo alone; the additional components of eac...
Valopicitabine in Biological News

Novel therapy combinations gain ground in treating hepatitis

... lead to more significant breakthroughs and relief for these patients." valopicitabine (NM283), Alone or with Peg-Interferon, Compared to Peg Interferon/Ribavirin...nts in patients who have not experienced remission with standard therapies: valopicitabine alone (800 mg/d), one of three combination arms with the drug at 400 mg/d, ...
Other Tags
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... Members receiving ... quality care metrics – at a cost that is nine percent lower -- than ... Cross Blue Shield of New Jersey’s patient-centered programs. , “The promise of patient-centered, ...
(Date:8/4/2015)... ... ... They say a picture is worth a thousand words, and when it ... be essential. StayWell, a health solutions company, announced today it will license KramesArt™ for ... by physicians and other health care providers for more than 40 years and are ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... with “Dr. Google” before calling a physician. In an effort to share more ... health care provider in Pennsylvania to publicly share patient satisfaction ratings and comments ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... design, product packaging, and fulfillment services, joined over 200 other Long Island-based corporations ... held on Tuesday, July 28th at Jones Beach State Park in Wantagh, New ...
(Date:8/4/2015)... ... August 04, 2015 , ... Patients ... now offered by the world renowned Beverly Hills facelift surgeon , Dr. ... cosmetic surgery techniques helps individuals to achieve an outer appearance that meets their ...
Breaking Medicine News(10 mins):Health News:Horizon BCBSNJ: 2014 Results Show Patient-Centered Care Continues to Deliver on Promise of Better Quality Care at a Lower Cost 2Health News:Horizon BCBSNJ: 2014 Results Show Patient-Centered Care Continues to Deliver on Promise of Better Quality Care at a Lower Cost 3Health News:StayWell Offers Instant Downloads, Licensing of Medical Art to Improve Patient Education 2Health News:StayWell Offers Instant Downloads, Licensing of Medical Art to Improve Patient Education 3Health News:UPMC 1st in Pa. to Share Provider Ratings 2Health News:UPMC 1st in Pa. to Share Provider Ratings 3Health News:NutraScience Labs "Steps Up" to the 2015 Marcum Workplace Challenge 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 3
(Date:8/4/2015)... 2015  AMRI (NASDAQ: AMRI ) today reported financial and ... Highlights: , Second quarter contract revenue of ... , Adjusted contract margins of 26 % ... a $0.05 decrease in EPS from royalties in the current quarter ... "We are very pleased to present another strong financial ...
(Date:8/3/2015)... SAN JOSE, Calif. , Aug. 3, 2015 /PRNewswire/ ... developer of human interface solutions, today announced that members ... investment community at the Pacific Crest Global Technology Leadership ... Mountain Time. The conference will be held at the ... The presentation may include forward-looking information. ...
(Date:7/31/2015)... 31. juli 2015 Den 10. internationale konference ... BGI fra den 22. - 25. oktober i ... sin 10-års fødselsdag i år. Siden starten i 2006 ... møder på ,omik,-feltet, og er en af de mest ... ICG-10 fokuserer på nylige gennembrud og fremskridt inden for ...
Breaking Biology News(10 mins):AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2
Other Contents